
Glimipack MV 2/0.3 Tablet SR
Marketer
Koye Pharmaceuticals Pvt ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Glimipack MV 2/0.3 Tablet SR
Diabexe Duo 2/0.3mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Administer Diabexe Duo with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is vital, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to complications like nephropathy, retinopathy, neuropathy, and peripheral vascular disease. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are crucial for effective diabetes control. Hypoglycemia (low blood sugar) is the most prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Maintain regular mealtimes and carry a quick-acting glucose source like candy or juice. Alcohol consumption elevates hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Its suitability during pregnancy or breastfeeding requires medical consultation. Regular blood glucose monitoring is essential, along with potential blood tests to assess blood cell counts and liver function.
Uses of Glimipack MV 2/0.3 Tablet SR
Managing Type 2 Diabetes
Major Benefits of Glimipack MV 2/0.3 Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Glimipack MV 2/0.3 Tablet SR on an empty stomach.
Common Side effects of Glimipack MV 2/0.3 Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glimipack MV 2/0.3 Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Glimipack MV 2/0.3 Tablet SR on an empty stomach.
How Glimipack MV 2/0.3 Tablet SR works:
Glimipack MV 2/0.3 sustained-release tablets contain a triple-drug formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Glimipack MV 2/0.3 Tablet SR is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Glimipack MV 2/0.3 SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any possible risks prior to prescription. Medical advice is recommended.
Breast feedingCONSULT YOUR DOCTOR
Employing Glimipack MV 2/0.3 SR tablets while breastfeeding is likely inadvisable. Available human data indicates potential drug transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such conditions arise.
KidneyUNSAFE
The use of Glimipack MV 2/0.3 Tablet SR is likely unsafe for individuals with kidney impairment and should be omitted. Medical advice is recommended. Furthermore, this medication is contraindicated in patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Glimipack MV 2/0.3 Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, Glimipack MV 2/0.3 Tablet SR initiation should involve a low dose; it's contraindicated in cases of severe hepatic dysfunction.
What if you forget to take Glimipack MV 2/0.3 Tablet SR :
Should you forget a Glimipack MV 2/0.3 Tablet SR dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimipack MV 2/0.3 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
